‘A blood test for Alzheimer’s — that’s a game-changer’ Siddharthan Chandran, head of the UK Dementia Research Institute, finds reasons to be hopeful, even if the NHS won’t offer the first ever treatment for the disease.
Read More
We are delighted to welcome Professor Siddharthan Chandran as the new director for the UK Dementia Research Institute (UK DRI). Professor Chandran joins the institute at a pivotal time, with recent advances in diagnosis and treatment renewing hope of progress…
Read More
Preclinical program with potential for disease modifying therapeutic. Edinburgh, UK January 11 2023 – Pheno Therapeutics Limited., biotechnology company focused on the discovery and development of small molecule therapeutics that promote remyelination for the treatment of neurological diseases such as…
Read More
An expert in regenerative neurology, Prof Siddharthan Chandran is the MacDonald Professor of Neurology, Director of Edinburgh Neuroscience and Head of Edinburgh Medical School. Prof Chandran’s research combines clinical and laboratory research to investigate the role of cellular interplay in…
Read More
Backed by Series A funding of £5 million over its first three years, Pheno Therapeutics will search for new drugs that aim to repair damage to the nervous system and significantly improve patients’ debilitating symptoms. Building on original research by…
Read More